News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
FDA
Novartis AG Sight Drug Gets Broader EU Approval
January 7, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
ZURICH, Jan 7 (Reuters) - Swiss drugmaker Novartis AG (NOVN.VX) said on Friday the European Commission has approved broader application of its Lucentis drug to treat visually impaired patients, giving sales of the drug a potential boost.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
Europe
Novartis
MORE ON THIS TOPIC
Government
Signs of Frustration Build Between Kennedy and FDA Commissioner Makary
November 17, 2025
·
2 min read
·
Tristan Manalac
Rare diseases
FDA Unwraps ‘Plausible Mechanism Pathway’ for Personalized Therapies
November 13, 2025
·
3 min read
·
Tristan Manalac
Job Trends
When, Not If: Job Market Should Start Turning Around in Next Year or So, Experts Say
November 13, 2025
·
6 min read
·
Angela Gabriel
Drug Development
Five Trends That Got Everyone Talking in Pharma and Biotech This Year
November 12, 2025
·
5 min read
·
Jennifer Smith-Parker
